High Tower Advisors, LLC Kodiak Sciences Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.09 - $89.45 $38,321 - $483,477	-5,405 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$80.85 - $128.49 $10,187 - $16,189	126 Added 2.39%	5,405 $458,000
Q3 2021 Nov 12, 2021	BUY	$81.97 - $106.94 $432,719 - $564,536	5,279 New	5,279 $504,000
Q4 2020 Feb 10, 2021	SELL	$60.78 - $154.03 $1.06 Million - $2.68 Million	-17,386 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$45.05 - $59.27 $256,830 - $337,898	5,701 Added 48.79%	17,386 $1.03 Million
Q2 2020 Aug 10, 2020	BUY	$42.74 - $66.25 $499,416 - $774,131	11,685 New	11,685 $633,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $303M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.